...
首页> 外文期刊>Die Pharmazie >Sinomenine reverses multidrug resistance in bladder cancer cells via p-glycoprotein-dependent and independent manners
【24h】

Sinomenine reverses multidrug resistance in bladder cancer cells via p-glycoprotein-dependent and independent manners

机译:青藤碱通过p-糖蛋白依赖和独立方式逆转膀胱癌细胞的多药耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

P-Glycoprotein-mediated multidrug resistance is a frequent event during chemotherapy and a key obstacle for bladder cancer therapy. Search for strategies to reverse multidrug resistance is a promising approach to improve the management of bladder cancer. In the present study, we reported a novel P-glycoproteinmediated multidrug resistant cell model 253J/DOX, which was generated from human bladder cancer 253J cell line. Furthermore, we found that the multidrug resistant phenotype of 253J/DOX cells could be overcome by sinomenine, an alkaloid derived from the stem of Sinomenium acutum. Mechanistically, the chemosensitive effect by sinomenine was mediated by down-regulating P-glycoprotein expression, as well as triggering apoptotic pathways. The chemosensitive effect of sinomenine may make it a prime candidate agent to target bladder cancer.
机译:P-糖蛋白介导的多药耐药性是化疗期间的常见事件,也是膀胱癌治疗的主要障碍。寻找逆转多药耐药性的策略是改善膀胱癌管理的一种有前途的方法。在本研究中,我们报道了一种新型的P-糖蛋白介导的多药耐药细胞模型253J / DOX,它是从人膀胱癌253J细胞系中产生的。此外,我们发现青藤碱可以克服253J / DOX细胞的多药耐药表型,青藤碱是一种从青霉菌茎衍生的生物碱。从机制上讲,青藤碱的化学敏感性作用是通过下调P-糖蛋白表达以及触发凋亡途径来介导的。青藤碱的化学敏感性可能使其成为靶向膀胱癌的主要候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号